Patient-Derived Xenograft Models of Colorectal Cancer

Robust, well characterized preclinical models are essential for the advancement of targeted therapies for colorectal cancer. Colon cancer patient-derived xenograft (PDX) models display a true representation of the human genetic and phenotypic heterogeneity seen in patient populations and provide the most accurate approach to predicting an agent’s efficacy prior to entering the clinic. Crown Bioscience has one of the largest collections of Colorectal cancer PDX models, including subcutaneous and orthotopic models to more closely recapitulate the tumor microenvironment. More

Benefits of Crown Bioscience's Colon cancer Patient derived xenograft model research

Our Colorectal cancer Patient-derived xenograft models offer the most translational preclinical model for efficacy screening in Colon cancer drug development. Derived directly from patient tumors and never adapted to grow in vitro, Patient derived xenograft reflects the heterogeneity and diversity of the human patient population. Colon cancer PDX model will give you an accurate, predictive model of how your treatment will perform, well before entering into expensive clinical trials. Crown Bioscience's HuPrime^® Rectal cancer PDX models are well characterized for pathology, growth characteristics, and are also genetically/genomically annotated for gene expression, gene copy number, mutations, and fusions.

MODEL NUMBER	CANCER TYPE	CANCER SUBTYPE	DESCRIPTION	# per page
CR0004	Colorectal Cancer	ADC	Adenocarcinoma of colon, protruded type, moderately differentiated, invaded through intestinal wall to peripheral adipose tissue. Regional LN: paraintestinal LN (1/7). IHC results: HER-1(-), HER-2(-), p53( 50~75%+), p170(-), Ki-67(25~50%+), VEGF(+++), Top-IIa(<25%+), p16(<25%+).	CLICK TO VIEW
CR0010	Colorectal Cancer	ADC	Adenocarcinoma of descending colon, carcinoma in situ, ulcerative type, well-moderately differentiated, tumor mass: 6cm x 4.5cm x 3.5cm.	CLICK TO VIEW
CR0012	Colorectal Cancer	ADC	Adenocarcinoma of rectum, ulcerative type, carcinoma in situ, moderately differentiated, tumor mass: 6cm x 5.5cm x 1.5cm.	CLICK TO VIEW
CR0024	Colorectal Cancer	ADC	Adenocarcinoma, moderately differentiated.	CLICK TO VIEW
CR0028	Colorectal Cancer	ADC	Adenocarcinoma of ascending colon with part of mucinous adenocarcinoma, carcinoma in situ, ulcerative type, moderately differentiated, tumor mass: 7cm x 4.5cm x 2cm.	CLICK TO VIEW
CR0029	Colorectal Cancer	ADC	Carcinoid, protruded type.	CLICK TO VIEW
CR0047	Colorectal Cancer	ADC	Moderately to poorly differentiated adenocarcinoma	CLICK TO VIEW
CR0126	Colorectal Cancer	Mucinous adenocarcinoma	Adenocarcinoma of the rectum with mucinous adenocarcinoma, moderately differentiated, ulcerative type, infiltrating into serosa, tumor mass: 5cm x 4cm x 1.5cm. No malignant cells adjacent to both stump. Regional LN: mesenteric LN (0/4).	CLICK TO VIEW
CR0133	Colorectal Cancer	ADC	Moderately differentiated adenocarcinoma	CLICK TO VIEW
CR0146	Colorectal Cancer	ADC	Adenocarcinoma with mucinous carcinoma, moderately-poorly differentiated, ulcerative type, infiltrating into serosa, tumor mass: 5cm x 4cm x 1cm. No malignant cells adjacent to both stump. Regional LN: mesenteric LN (0/5).	CLICK TO VIEW
CR0150	Colorectal Cancer	ADC	Adenocarcinoma of cecum, moderately-poorly differentiated, ulcerative type, infiltrating into serosa, tumor mass: 5cm x 5cm x 1cm. No malignant cells adjacent to both stump. Regional LN: mesenteric LN (3/6).	CLICK TO VIEW
CR0170	Colorectal Cancer	ADC	Adenocarcinoma of rectum, ulcerative type, moderately-poorly differentiated, infiltrating into deep muscular layer, tumor mass: 4cm x 3cm x 1cm. No malignant cells adjacent to both stump. Regional LN: mesenteric LN (0/2).	CLICK TO VIEW
CR0193	Colorectal Cancer	ADC	Adenocarcinoma of colon, moderately differentiated, ulcerative type, infiltrating into serosa, tumor mass: 6.5cm x 4.5cm x 1.5cm. No malignant cells adjacent to both stump. Regional LN: mesenteric LN (0/9).	CLICK TO VIEW
CR0196	Colorectal Cancer	ADC	Adenocarcinoma of the rectum, moderately differentiated, ulcerative type, infiltrating into serosa, tumor mass: 3.5cm x 3cm x 0.8cm. No malignant cells adjacent to both stump. Regional LN: mesenteric LN (8/10).	CLICK TO VIEW
CR0205	Colorectal Cancer	ADC	1.Adenocarcinoma of transverse colon, moderately-poorly differentiated, infiltrative type, invaded serosa, tumor mass: 8cm x 7cm x 1.5cm. No malignant cells adjacent to both stump. Regional LN: mesenteric LN(1/7). 2.Adenocarcinoma of duodenal papilla, moderately-poorly differentiated, invaded submucosa, tumor mass: 2.4cm x 1.2cm x 1cm. No malignant cells adjacent to both stump and pancreatic stump. Regional LN: parahepatic artery LN (0/2), LN surround common hepatic duct (0/3), greater curvature LN (0/2), parapyloric LN (0/8), parapancreatic LN (0/1).	CLICK TO VIEW
CR0231	Colorectal Cancer	ADC	Moderately differentiated adenocarcinoma with part of mucinous adenocarcinoma	CLICK TO VIEW
CR0245	Colorectal Cancer	ADC, Mucinous	Mucinous adenocarcinoma	CLICK TO VIEW
CR0455	Colorectal Cancer	ADC	Adenocarcinoma of colon, poorly differentiated.	CLICK TO VIEW
CR0460	Colorectal Cancer	ADC	Metastatic adenocarcinoma in liver. Chronic cholecystitis. Regional LN: LN of external gallbladder wall (2/2).	CLICK TO VIEW
CR0560	Colorectal Cancer	ADC	Moderately to poorly differentiated adenocarcinoma	CLICK TO VIEW
CR0588	Colorectal Cancer	ADC	Moderately differentiated adenocarcinoma	CLICK TO VIEW
CR10901	Colorectal Cancer	NA	Colon Carcinoma. C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP.	CLICK TO VIEW
CR11370	Colorectal Cancer	NA	NA	CLICK TO VIEW
CR11372	Colorectal Cancer	NA	Small Intestine Carcinoma, FS: favor adenocarcinoma.	CLICK TO VIEW
CR11374	Colorectal Cancer	ADC	N/A	CLICK TO VIEW
CR11377	Colorectal Cancer	ADC	N/A	CLICK TO VIEW
CR1197	Colorectal Cancer	ADC	Metastatic adenocarcinoma to lung, consider metastatic intestinal adenocarcinoma. Cubical and columnar tumor cells form irregular adenoid structures and has an infiltrative growth pattern. Pools of mucin may be seen. Regional LN: parabronchial LN (0/2), the eleventh group LN (0/3).	CLICK TO VIEW
CR1207	Colorectal Cancer	ADC	Adenocarcinoma of right lung, moderately differentiated, tumor mass: 4cm x 4cm x 3cm.	CLICK TO VIEW
CR1231	Colorectal Cancer	ADC	Metastatic adenocarcinoma of LN of porta hepatis. The tumor forms irregular glandular structures and has an infiltrative growth pattern.	CLICK TO VIEW
CR1245	Colorectal Cancer	ADC	Adenocarcinoma of right lung, moderately differentiated (mixed type, include acinic cell adenocarcinoma and mucinous adenocarcinoma.) Pathology QC: Moderately differentiated adenocarcinoma (P0); Poorly differentiated squamous cell carcinoma (P2).	CLICK TO VIEW
CR1281	Colorectal Cancer	ADC	Metastatic adenocarcinoma of righ lung, poorly differentiated, tumor mass: 2cm x 1.8cm x 1.5cm, malignant cells invaded visceral pleura.	CLICK TO VIEW
CR1287	Colorectal Cancer	ADC	Metastatic colonic adenocarcinoma to liver. The neoplastic cells are cubical columnar cells with the nuclear atypia and abaundant cytoplasm or mucous cytoplasm. The tumor forms irregular tubular structures and has an infiltrative growth pattern. Peripheral hepatic tissues have normal hepatic lobular structures with mild lymphocyte infiltrating portal area.	CLICK TO VIEW
CR1305	Colorectal Cancer	ADC	Metastatic adenocarcinoma to lung, consider rectal carcinoma on basis of medical history.	CLICK TO VIEW
CR1400	Colorectal Cancer	ADC, Mucinous	Villous-tubular adenoma of sigmoid with lower grade intraepithelial neoplasia.	CLICK TO VIEW
CR1428	Colorectal Cancer	ADC	Moderately differentiated adenocarcinoma of sigmoid with hepatic metastases. Tumor cells show columnar with the nuclear atypia. The tumor forms tubular and cribriform structures and has an infiltrative growth pattern. Regional LN: mesenteric LN (2/28).	CLICK TO VIEW
CR1451	Colorectal Cancer	ADC	Metastatic adenocarcinoma to greater omentum. The tumor forms irregular glandular or cribriform structures and has an infiltrative growth pattern.	CLICK TO VIEW
CR1489	Colorectal Cancer	ADC	Moderately differentiated adenocarcinoma of rectum. The neoplastic cells are column or cube and are associated with a certain mitotic count. The tumor forms glandular and nest structures toghter with pools of mucin in it and has an infiltrative growth pattern. Mild of signed ring cell are viewed.	CLICK TO VIEW
CR14931	Colorectal Cancer	NA	NA	CLICK TO VIEW
CR14939	Colorectal Cancer	ADC	N/A	CLICK TO VIEW
CR15091	Colorectal Cancer	ADC	N/A	CLICK TO VIEW
CR15134	Colorectal Cancer	ADC	N/A	CLICK TO VIEW
CR1519	Colorectal Cancer	ADC	Poorly differentiated adenocarcinoma	CLICK TO VIEW
CR1520	Colorectal Cancer	ADC	Moderately-poorly differentiated adenocarcinoma	CLICK TO VIEW
CR15287	Colorectal Cancer	ADC	N/A	CLICK TO VIEW
CR1530	Colorectal Cancer	ADC	Moderately differentiated adenocarcinoma	CLICK TO VIEW
CR15303	Colorectal Cancer	ADC	N/A	CLICK TO VIEW
CR15339	Colorectal Cancer	ADC	N/A	CLICK TO VIEW
CR15449	Colorectal Cancer	ADC	N/A	CLICK TO VIEW
CR1554	Colorectal Cancer	ADC	Adenocarcinoma of rectum, ulcerative type, moderately differentiated, invade muscle layer to rectal adventitia, tumor mass: 5cm x 5cm x 2cm. No malignant cells adjacent to superior and inferior stump. Mesenteric LN (0/7).	CLICK TO VIEW
CR1559	Colorectal Cancer	ADC	NA for clinical diagnosis info.	CLICK TO VIEW
CR1560	Colorectal Cancer	ADC	Poorly differentiated adenocarcinoma	CLICK TO VIEW
CR1563	Colorectal Cancer	ADC	Adenocarcinoma of rectum, ulcerative type, moderately differentiated, invaded peripheric adipose tissue. No malignant cells adjacent to both stump. Reginol LN: surrounding intestin LN (0/4).	CLICK TO VIEW
CR15630	Colorectal Cancer	NA	NA	CLICK TO VIEW
CR1564	Colorectal Cancer	ADC	NA for clinical diagnosis info.	CLICK TO VIEW
CR15700	Colorectal Cancer	ADC	N/A	CLICK TO VIEW
CR15701	Colorectal Cancer	NA	NA	CLICK TO VIEW
CR15724	Colorectal Cancer	ADC	N/A	CLICK TO VIEW
CR15726	Colorectal Cancer	ADC	N/A	CLICK TO VIEW
CR1574	Colorectal Cancer	ADC	Mucinous adenocarcinoma	CLICK TO VIEW
CR15765	Colorectal Cancer	ADC	N/A	CLICK TO VIEW
CR15770	Colorectal Cancer	NA	NA	CLICK TO VIEW
CR15788	Colorectal Cancer	ADC	N/A	CLICK TO VIEW
CR1634	Colorectal Cancer	ADC	Well differentiated adenocarcinoma	CLICK TO VIEW
CR1742	Colorectal Cancer	ADC, Mucinous	Mucinous adenocarcinoma	CLICK TO VIEW
CR1744	Colorectal Cancer	ADC	Moderately differentiated adenocarcinoma	CLICK TO VIEW
CR1795	Colorectal Cancer	ADC	Adenocarcinoma, ulcerative type, moderately-poorly differentiated, invade through intestinal wall to adipose tissue. No malignant cells adjacent to both stump. Reginol LN: paraintestinal LN (0/27).IHC results: CK7(-), CK20(+), EGFR(++), P53(+), Ki-67(80%+), Villin(+++), CerbB-2(+), OCT3/4(-).	CLICK TO VIEW
CR1801	Colorectal Cancer	ADC	Adenocarcinoma of duodenal papilla, tumor invade pancreas and surrounding soft tissue. Regional LN: the 12th LN: 0/1.	CLICK TO VIEW
CR2037	Colorectal Cancer	ADC	Adenocarcinoma, NOS	CLICK TO VIEW
CR2046	Colorectal Cancer	ADC	Adenocarcinoma, NOS	CLICK TO VIEW
CR2054	Colorectal Cancer	ADC, mucinous	mucinous adenocarcinoma	CLICK TO VIEW
CR2060	Colorectal Cancer	ADC	Adenocarcinoma, NOS	CLICK TO VIEW
CR2069	Colorectal Cancer	NA	Colon (liver mets)	CLICK TO VIEW
CR2072	Colorectal Cancer	NA	Liver Tissue Mets from Rectum	CLICK TO VIEW
CR2073	Colorectal Cancer	NA	Sigmoid Colon (Intramucosal Carcinoma)	CLICK TO VIEW
CR2079	Colorectal Cancer	NA	Lung Mets from Colorectal Adeno Carcinoma	CLICK TO VIEW
CR2083	Colorectal Cancer	ADC	Sigmoid Colon Adenocarcinoma	CLICK TO VIEW
CR2084	Colorectal Cancer	ADC	Liver Mets from Colon Adenocarcinoma	CLICK TO VIEW
CR2110	Colorectal Cancer	ADC	Adenocarcinoma in sigmoid colon, moderately-poorly differentiated, ulcerative type, invade serosa and adhere small intestine, tumor mass: 6cm x 4cm. No malignant cells adjacent to superior and inferior stump. Regional LN: peri-colon LN (0/16), peri-small intestine LN (0/4).	CLICK TO VIEW
CR2161	Colorectal Cancer	ADC	Moderately adenocarcinoma of colon, with part of mucous adenocarcinoma, ulcerative type, tumor mass: 6.0 x 4.0cm. The tumor invade through intestinal wall but not to intestinal serosa. Regional LN: paraintestinal LN (2/19), omental LN (0/1), LN of superior and root mesenteric artery (0/2), LN of middle colic artery (0/1). IHC results: CD44(+), cMet(+), COX2(+), EGFR(+), HER2(1+), Ki-67(+25-50%), MLH1(-), MMP7(+<25%), MSH2(+<25%), MSH6(+>75%), P170(+), P27(+<25%), P53(+<25%), TOPOII(+<25%).	CLICK TO VIEW
CR2178	Colorectal Cancer	ADC	Rectal carcinoma	CLICK TO VIEW
CR2179	Colorectal Cancer	ADC	Adenocarcinoma	CLICK TO VIEW
CR2226	Colorectal Cancer	ADC, mucinous adenocarcinoma	Mucinous adenocarcinoma of colon, protruded type, with part of moderately differentiated adenocarcinoma, tumor mass: 6.5cm x 3.5cm. Malignant cells invade peripheral adipose tissue. Regional LN: paraintestinal LN (3/47), LN of ligamentum hepatoduodenale (0/1), LN of porta hepatis (0/5). IHC results: CD44(+), cMet(-), COX2(+), EGFR(-), HER2(1+), Ki67(+25-50%), MLH1(+50-75%), MMP7(weak +), MSH2(+<25%), MSH6(+50-75%), P170(+), P27(+<25%), P53(-), TOPOII(-).	CLICK TO VIEW
CR2229	Colorectal Cancer	ADC	Rectal adenocarcinoma,moderately differentiated.	CLICK TO VIEW
CR2241	Colorectal Cancer	ADC, mucinous adenocarcinoma	Mucinous adenocarcinoma of rectum, ulcerative type, tumor mass: 4.0cm x 3.5cm. The tumor invade through intestinal wall. Cancer embolus in vessel may be seen. Regional LN: 5/10. IHC results: CD44(+), cMet(+), COX2(+), EGFR(+), Hep(-), HER2(-), Ki-67(-), MLH1(>75%+), MMP7(+), MSH2(25~50%+), MSH6(>75%+), P170(+), P27(25~50%+), P53(-), TOPOII(<25%+).	CLICK TO VIEW
CR2244	Colorectal Cancer	NA	Sigmoid colon: moderately differentiated adenocarcinoma.	CLICK TO VIEW
CR2258	Colorectal Cancer	ADC	Invasion adenocarcinoma of sigmoid, poorly differentiated.	CLICK TO VIEW
CR2305	Colorectal Cancer	ADC	Moderately differentiated adenocarcinoma of sigmoid colon.	CLICK TO VIEW
CR2327	Colorectal Cancer	Adenocarcinoma	NA	CLICK TO VIEW
CR2394	Colorectal Cancer	NA	Sigmoid colon: carcinoma of sigmoid, metastases to liver and ovary. EGFR partial positive, Her2(-).	CLICK TO VIEW
CR2408	Colorectal Cancer	ADC	Adenocarcinoma, stage IV	CLICK TO VIEW
CR2412	Colorectal Cancer	NA	Mucinous Carcinoma	CLICK TO VIEW
CR2441	Colorectal Cancer	NA	Sigmoid colon: carcinoma of sigmoid, metastases to liver and ovary.	CLICK TO VIEW
CR2491	Colorectal Cancer	NA	Rectum: moderately differentiated adenocarcinoma, ulcerative type. Tumor infiltrated through intestinal wall to serosa and the serosa of uterine wall, metastatic tumor foci could be seen in liver. Six of thirty lymph nodes involved by metastatic carcinoma (6/30).	CLICK TO VIEW
CR2501	Colorectal Cancer	ADC	Moderately differentiated adenocarcinoma	CLICK TO VIEW
CR2502	Colorectal Cancer	ADC	Adenocarcinoma of colon, protruded type, poorly differentiated, invaded peripheral adipose tissue. No malignant cells adjacent to both stump. Reginol LN: paraintestinal LN (5/17). IHC results: Syn(-), CHgA(-), NSE(-), CK7(-), CK20(++), Villin(+), CA199(++), CEA(++), P53(+), Ki67(80%+).	CLICK TO VIEW
CR2506	Colorectal Cancer	ADC, mucinous adenocarcinoma	Adenocarcinoma from junction of rectum and sigmoid, moderately differentiated. Regional LN: paraintestinal LN (0/10). IHC results: CK(-), CK20(-).	CLICK TO VIEW
CR2508	Colorectal Cancer	ADC	Adenocarcinoma of colon, ulcerative type, moderately differentiated, malignant cell infiltrating through intestinal wall to adipose tissue. Regional LN: mesenteric LN of colon (3/7), mesenteric LN of ileum (0/1). IHC results: CK20(+++), CK7(-), P53(+++), Ki-67(60%+), CEA(+), CA199(+). Chronic appendicitis.	CLICK TO VIEW
CR2516	Colorectal Cancer	ADC	Mucinous adenocarcinoma of colon, poorly differentiated, with part of signet ring cell carcinoma. Metastatic tumor foci to peritoneum may be seen. Regional LN: peripheral LN (13/26). IHC results: CK7(-), CK20(++), Ki67(70%+), CerbB-2(+/-). Special stain: PAS-AB(+).	CLICK TO VIEW
CR2517	Colorectal Cancer	ADC	Adenocarcinoma of sigmoid colon, ulcerative type, moderately differentiated, invaded through intestinal wall. No malignant cells adjacent to both stump. Reginol LN: paraintestinal LN (1/19). IHC results: CD44(+), Cmet(+), COX2(+), EGFR(+), HER2(1+), Ki-67(+50-75%), MLH1(+>75%), MMP7(+), MSH2(+>75%), MSH6(+>75%), P170(+), P27(+<25%), P53(+>75%), TOPOII(+50-75%).	CLICK TO VIEW
CR2518	Colorectal Cancer	ADC	Adenocarcinoma of ascending colon, ulcerative type, poorly differentiated, invade through intestinal wall to peripheric adipose tissue. No malignant cells adjacent to superior and inferior stump. Regional LN: paraintestinal LN (0/17). IHC results: CK7(+/-), CK20(++), Syn(+++), CD56(-), Ki-67(60%+), CerbB-2(-), VEGF(-), D2-40(lymphatic vessel +).	CLICK TO VIEW
CR2519	Colorectal Cancer	ADC	Moderately differentiated adenocarcinoma of rectum, ulcerative type, tumor mass: 3.0 x 2.5cm. The tumor invade through intestinal wall to peripheral intestinal adipose tissue (T3). Regional LN: paraintestinal LN 4/13. IHC results: CD44(+), cMet(+), COX2(+), EGFR(+), HER2(-), Ki-67(+>75%), MLH1(+>75%), MMP7(weak +<25%), MSH2(-), MSH6(+>75%), P170(+), P27(+), P53(-), TOPOII(+<25%).	CLICK TO VIEW
CR2520	Colorectal Cancer	ADC	Adenocarcinoma of colon, protruded ulcerative type, moderately differentiated, invaded through intestinal wall. No malignant cells adjacent to both stump. Reginol LN: paraintestinal LN (0/26). IHC results:CD44(+), Cmet(+), COX2(+), EGFR(+), HER2(1+), Ki-67(+>75%), MLH1(-), MMP7(+), MSH2(+50-75%), MSH6(+>75%), P170(+), P27(+<25%), P53(+<25%), TOPOII(+<25%).	CLICK TO VIEW
CR2521	Colorectal Cancer	ADC	Well to moderately differentiated adenocarcinoma of sigmoid colon, protruded type, tumor mass: 5.0 x 4.0 x 0.8cm. Tumor invades intestinal wall to subserosa fibrous tissue. Regional LN: paraintestinal LN (0/19). IHC results: CD44(+++), cMet(+++), COX2(+), EGFR(+), HER2(2+), Ki-67(+>75%), MLH1(+>75%), MMP7(-), MSH2(+>75%), MSH6(+>75%), P170(+), P27(+50~75%), P53(-), TOPOII(+50~75%). Vascular Invasion:neg. Infection Screening (HBV/HCV/HIV/TP):neg.	CLICK TO VIEW
CR2523	Colorectal Cancer	ADC	Rectal adenocarcinoma,ulcerative type, moderate differentiated, tumor mass: 5 x 4cm, invasive through all intestinal wall. IHC results: CD44(+), cMET(+), COX2(+), EGFR(+), HER2(-), Ki-67(+>75%), MLH1(+>75%), MMP7(+), MSH2(+>75%), MSH6(+>75%), P170(+), P27(+50-75%), P53(+>75%), TOPOII(+50-75%). Vascular Invasion: neg. Infection Screening(HBV/HCV/HIV/TP): neg. Regional LN: paraintestinal LN (0/20).	CLICK TO VIEW
CR2524	Colorectal Cancer	ADC	Tubular adenocarcinoma of colon, ulcerative type, moderately differentiated, diameter: 4cm,invaded adipose tissue external serosa. No malignant cells adjacent to both stump. Reginol LN: paraintestinal LN (0/20).	CLICK TO VIEW
CR2525	Colorectal Cancer	ADC	N/A	CLICK TO VIEW
CR2526	Colorectal Cancer	ADC	Moderately adenocarcinoma of sigmoid colon, ulcerative type, tumor mass: 3 x 3cm. The tumor invade through intestinal wall to peripheral adipose tissue. Regional LN: paraintestinal LN 8/23, root of mesenteric LN 0/2. IHC results: CD44(+), cMet(+), COX2(-), EGFR(-), HER2(-), Ki-67(+>75%), MLH1(+>75%), MMP7(-), MSH2(+>75%), MSH6(+>75%), P170(-), P27(+25~50%), P53(-), TOPOII(+>75%).	CLICK TO VIEW
CR2528	Colorectal Cancer	ADC	Tubular adenocarcinoma of ascending colon, moderately differentiated, ulcerative type, tumor mass: 4.5cm x 4cm x 0.8cm. Regional LN: mesenteric LN (0/20).	CLICK TO VIEW
CR2530	Colorectal Cancer	ADC, mucinous adenocarcinoma	Adenocarcinoma of rectum, moderately differentiated, protruded type. Regional LN: mesenteric LN (0/21). IHC results: P53(+), Ki67(80%+), CK7(-), CK20(+++), Villin(+++), CA199(+).	CLICK TO VIEW
CR2531	Colorectal Cancer	Mucinous adenocarcinoma	Adenocarcinoma of colon, moderately differentiated, protruded type, with part of mucinous adenocarcinoma. The tumor invade through intestinal wall to peripheral adipose tissue. Regional LN: Three of thirty lymph node involved by metastatic carcinoma (3/30). IHC results: CK7(-), CK20(++), Villin(++), P53(++), Ki-67(80%+), EGFR(+).	CLICK TO VIEW
CR2533	Colorectal Cancer	ADC	Adenocarcinoma of rectum, moderately differentiated, ulceratived type, tumor mass: 6 x 4cm. The tumor invade through intestinal wall. Regional LN: paraintestinal LN (0/14). IHC results: CD44(+), cMet(+), COX2(+), EGFR(focal +), HER2(3+), Ki-67(+25-50%), MLH1(+>75%),MMP7(-),MSH2(+50-75%),MSH6(+>75%),P170(+),P27(+50-75%),P53(-),TOPOII(+25-50%). Vascular Invasion:neg;Infection Screening (HBV/HCV/HIV/TP):neg.	CLICK TO VIEW
CR2545	Colorectal Cancer	ADC	Adenocarcinoma of ascending colon, ulcerative type, poorly differentiated, invade through intestinal wall to peripheric adipose tissue. No malignant cells adjacent to superior and inferior stump. Regional LN: paraintestinal LN (0/17). IHC results: CK7(+/-), CK20(++), Syn(+++), CD56(-), Ki-67(60%+), CerbB-2(-), VEGF(-), D2-40(lymphatic vessel +).	CLICK TO VIEW
CR2554	Colorectal Cancer	NA	Lung Met from Colon ADC	CLICK TO VIEW
CR2556	Colorectal Cancer	NA	Small Bowel (Jejunum) ADC	CLICK TO VIEW
CR2558	Colorectal Cancer	ADC	N/A	CLICK TO VIEW
CR2559	Colorectal Cancer	NA	NA for clinical diagnosis info.	CLICK TO VIEW
CR2560	Colorectal Cancer	NA	NA for clinical diagnosis info.	CLICK TO VIEW
CR2564	Colorectal Cancer	NA	NA for clinical diagnosis info.	CLICK TO VIEW
CR2565	Colorectal Cancer	NA	NA for clinical diagnosis info.	CLICK TO VIEW
CR2568	Colorectal Cancer	ADC	N/A	CLICK TO VIEW
CR2627	Colorectal Cancer	NA	Rectal Adenocarcinoma	CLICK TO VIEW
CR2814	Colorectal Cancer	NA	Hepatic metastasis of clonic carcinoma	CLICK TO VIEW
CR2822	Colorectal Cancer	NA	Hepatic metastasis of clonic carcinoma	CLICK TO VIEW
CR2828	Colorectal Cancer	NA	NA	CLICK TO VIEW
CR2831	Colorectal Cancer	NA	Hepatic metastasis of clonic carcinoma	CLICK TO VIEW
CR2832	Colorectal Cancer	ADC	N/A	CLICK TO VIEW
CR2837	Colorectal Cancer	ADC	N/A	CLICK TO VIEW
CR2848	Colorectal Cancer	NA	NA	CLICK TO VIEW
CR2849	Colorectal Cancer	NA	NA	CLICK TO VIEW
CR2856	Colorectal Cancer	NA	NA	CLICK TO VIEW
CR2857	Colorectal Cancer	NA	NA	CLICK TO VIEW
CR2864	Colorectal Cancer	NA	NA	CLICK TO VIEW
CR3015	Colorectal Cancer	ADC	Adenocarcinoma of sigmoid colon, moderately differentiated. Regional LN: mesenteric LN (4/16).	CLICK TO VIEW
CR3056	Colorectal Cancer	ADC	Moderately differentiated adenocarcinoma of rectum	CLICK TO VIEW
CR3077	Colorectal Cancer	ADC	Serous adenocarcinoma of right ovary with necrosis, grade II. The malignant cell may be seen in the node of left uterus.	CLICK TO VIEW
CR3078	Colorectal Cancer	ADC	1. Moderately differentiated adenocarcinoma of colon. The tumor forms irregular glandular or cribriform structures and has an infiltrative growth pattern. Regional LN: mesenteric LN (2/11). 2. Metastatic adenocarcinoma to liver	CLICK TO VIEW
CR3079	Colorectal Cancer	ADC	Moderately differentiated adenocarcinoma of rectum, invasive growth. Regional LN: external rectal LN (5/14).	CLICK TO VIEW
CR3085	Colorectal Cancer	ADC	Poorly differentiated adenocarcinoma of right colon. Tumor cells show columnar with rotundity and oval nuclear. Tubular and streak tumors are seen, toghter with invasive growth. Regional LN: mesenteric LN (5/18).	CLICK TO VIEW
CR3099	Colorectal Cancer	ADC	Pathology QC: Moderately differentiated adenocarcinoma (P2).	CLICK TO VIEW
CR3101	Colorectal Cancer	ADC	Moderately differentiated adenocarcinoma of transverse colon with hepatic metastases. The tumor forms tubular, nesting and papillary structures and has an infiltrative growth pattern. Regional LN: mesenteric LN (13/37). Chronic appendicitis. Chronic cholecystitis.	CLICK TO VIEW
CR3105	Colorectal Cancer	ADC	1. Metastatic or invasive adenocarcinoma of bilateral ovary with massive necrosis, grade II. 2. Adenocarcinoma of colon, grade II, protruded type. Regional LN: paraileac LN (0/5), paracolonic LN (0/4), NO.6 LN (0/1), paracaecal LN (2/15).	CLICK TO VIEW
CR3107	Colorectal Cancer	ADC	Metastatic adenocarcinoma to liver, consider rectal adenocarcinoma on basis of medical history. The tumor forms tubular structures. Tumor cells show tall column with pleomorphism, prominent nucleoli.	CLICK TO VIEW
CR3114	Colorectal Cancer	ADC	Moderately differentiated adenocarcinoma of ascending colon. The tumor forms glandular or cribriform structures and has an infiltratived growth pattern. Regional LN: mesenteric LN (2/15). Mixed hyperplastic adenomatous polyp. Chronic appendicitis.	CLICK TO VIEW
CR3150	Colorectal Cancer	ADC, mucinous adenocarcinoma	Adenocarcinoma of colon with part of mucinous adenocarcinoma, moderately differentiated. Tumor cells show columnar with circular or oval nuclear. The tumor forms tubular or nest structures and has an infiltrative growth pattern. Poors of mucin in glandular cavity may be seen. Regional LN: mesenteric LN (5/20).	CLICK TO VIEW
CR3151	Colorectal Cancer	ADC	Moderately differentiated adenocarcinoma of transverse colon. The tumor forms cribriform, glandular structures and has an infiltrative growth pattern. Regional LN: mesnteric LN (4/12). Gastrointestinal stromal tumor of Meckel's diverticulum.	CLICK TO VIEW
CR3157	Colorectal Cancer	ADC, mucinous adenocarcinoma	Moderately differentiated adenocarcinoma of rectum. The tumor forms irregular glandular or cribriform structures and has an infiltrative growth pattern. Mucous secretiona may be seen. Regional LN: rectal LN (4/11).	CLICK TO VIEW
CR3211	Colorectal Cancer	Adenocarcinoma	Transverse colon: moderately differentiated adenocarcinoma. Two of ninteen lymph nodes involved by metastatic carcinoma (2/19)	CLICK TO VIEW
CR3235	Colorectal Cancer	ADC, mucinous adenocarcinoma	NA for clinical diagnosis info.	CLICK TO VIEW
CR3253	Colorectal Cancer	ADC	Ascending colon: moderately differentiated adenocarcinoma	CLICK TO VIEW
CR3262	Colorectal Cancer	ADC	Rectum: moderately differentiated adenocarcinoma. The tumor infiltated through intestinal wall to subserosa. Six out of fifteen lynph nodes showed metastatic adenocarcinoma.	CLICK TO VIEW
CR3278	Colorectal Cancer	Mucinous adenocarcinoma	Moderately differentiated adenocarcinoma, with part of mucinous adenocarcinoma	CLICK TO VIEW
CR3279	Colorectal Cancer	ADC	ADC with mucinous adenocarcinoma	CLICK TO VIEW
CR3280	Colorectal Cancer	ADC	Rectum: moderately differentiated adenocarcinoma with mucinous adenocarcinoma component. Five of fifteen lymph nodes involved by metastatic carcinoma (5/15).	CLICK TO VIEW
CR3300	Colorectal Cancer	ADC, mucinous adenocarcinoma	Moderately differentiated adenocarcinoma, with part of mucinous adenocarcinoma	CLICK TO VIEW
CR3310	Colorectal Cancer	ADC	Adenocarcinoma of sigmoid, grade II-III, infiltrating to serosa. Five of thirteen lymph nodes involved by metastatic carcinoma (5/13).	CLICK TO VIEW
CR3311	Colorectal Cancer	ADC	Sigmoid colon: adenocarcinoma, grade II-III, infiltrating to serosa. Five of thirteen lymph nodes involved by metastatic carcinoma (5/13).	CLICK TO VIEW
CR3315	Colorectal Cancer	ADC	Ascending colon: moderately differentiated adenocarcinoma, infiltrating to serosa. Three of twenty lymph nodes involved by metastatic carcinoma (3/20).	CLICK TO VIEW
CR3344	Colorectal Cancer	ADC	Rectum: poorly differentiated adenocarcinoma	CLICK TO VIEW
CR3348	Colorectal Cancer	ADC, mucinous adenocarcinoma	Ileocecal junction: moderately differentiated adenocarcinoma with mucinous adenocarcinoma component. Four of twenty-three lymph nodes involved by metastatic carcinoma (4/23).	CLICK TO VIEW
CR3398	Colorectal Cancer	ADC	Sigmoid: adenocarcinoma, grade II, stage pT3N2Mx, infiltrating to serosa. Nine of fifteen lymph nodes involved by metastatic carcinoma (9/15)	CLICK TO VIEW
CR3403	Colorectal Cancer	ADC	Rectal adenocarcinoma, grade II. The tumor infiltrated deep muscularis. There are multiple regional lymph nodes metastases. 21 out of 35 lymph nodes show metastatic adenocarcinoma.	CLICK TO VIEW
CR3406	Colorectal Cancer	ADC	N/A	CLICK TO VIEW
CR3424	Colorectal Cancer	ADC	Colon: adenocarcinoma, moderately differentiated, infiltrating to subserosa.	CLICK TO VIEW
CR3444	Colorectal Cancer	ADC	Duodenum: moderately differentiated adenocarcinoma with metastasis to lymph nodes surrounding pancreas	CLICK TO VIEW
CR3448	Colorectal Cancer	ADC	Metastatic adenocarcinoma from liver, consider colorectal carcinoma based on morphology and medical history.	CLICK TO VIEW
CR3469	Colorectal Cancer	ADC	Adenocarcinoma of colon, grade II, infiltrating to serosa and omentum majus. Two of twenty-three lymph nodes involved by metastatic carcinoma (2/23).	CLICK TO VIEW
CR3485	Colorectal Cancer	ADC	Rectum: adenocarcinoma, grade II-III, infiltrating adipose tissue surrounding intestine, metastasis to liver. Three of fourteen lymph nodes involved by metastatic carcinoma (3/14)	CLICK TO VIEW
CR3486	Colorectal Cancer	NA	NA for clinical diagnosis info.	CLICK TO VIEW
CR3496	Colorectal Cancer	ADC	Colon, ileocecal junction: adenocarcinoma, grade II-III, infiltrating to serosa. One of sixteen lymph nodes involved by metastatic carcinoma (1/16).	CLICK TO VIEW
CR3547	Colorectal Cancer	NA	Metastatic mucinous adenocarcinoma from tissue surrounding umbilical opening	CLICK TO VIEW
CR3565	Colorectal Cancer	ADC	Ileocecal junction: adenocarcinoma, grade II, infiltrating to peri-intestinal adipose tissue, metastasis to liver.	CLICK TO VIEW
CR3566	Colorectal Cancer	ADC	Colorectal Cancer, adenocarcinoma.	CLICK TO VIEW
CR3586	Colorectal Cancer	NA	NA	CLICK TO VIEW
CR3592	Colorectal Cancer	ADC	NA for clinical diagnosis info.	CLICK TO VIEW
CR3594	Colorectal Cancer	NA	NA for clinical diagnosis info.	CLICK TO VIEW
CR3595	Colorectal Cancer	NA	NA for clinical diagnosis info.	CLICK TO VIEW
CR3612	Colorectal Cancer	NA	NA for clinical diagnosis info.	CLICK TO VIEW
CR3803	Colorectal Cancer	NA	NA	CLICK TO VIEW
CR3804	Colorectal Cancer	ADC	NA for clinical diagnosis info.	CLICK TO VIEW
CR3808	Colorectal Cancer	Adenocarcinoma	N/A	CLICK TO VIEW
CR3811	Colorectal Cancer	Adenocarcinoma	N/A	CLICK TO VIEW
CR3814	Colorectal Cancer	NA	NA	CLICK TO VIEW
CR3819	Colorectal Cancer	adenocarcinoma	NA	CLICK TO VIEW
CR3820	Colorectal Cancer	Adenocarcinoma	NA	CLICK TO VIEW
CR3825	Colorectal Cancer	Adenocarcinoma	N/A	CLICK TO VIEW
CR5026	Colorectal Cancer	ADC	adenocarcinoma, metastatic, pd	CLICK TO VIEW
CR5027	Colorectal Cancer	NA	recurrent colon carcinoma. Pathol comment: c/w referring diagnosis. approximately 30% of the tissue involved by tumor in sections examined. tumor cells present in cytospin prep.	CLICK TO VIEW
CR5028	Colorectal Cancer	ADC	colon carcinoma adenocarcinoma. Pathol comment: c/w referring diagnosis. approximately 30% of the tissue involved by tumor in sections examined. tumor cells present in cytospin prep.	CLICK TO VIEW
CR5029	Colorectal Cancer	ADC	colon cancer metastatic adenocarcinoma. Pathol comment: c/w diagnosis. approximately 30% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep.	CLICK TO VIEW
CR5030	Colorectal Cancer	ADC	colon carcinoma adenocarcinoma. Pathol comment: c/w diagnosis. approx. 60% of the tissue involved by malignant tumor in sections examined. 30% necrosis. rare tumor cells present in cytospin prep.	CLICK TO VIEW
CR5032	Colorectal Cancer	ADC	colon carcinom ametastatic adenocarcinoma. Pathol comment: c/w diagnosis. approximately 90% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep.necro	CLICK TO VIEW
CR5033	Colorectal Cancer	NA	colon carcinoma. Pathol comment: c/w diagnosis. approximately 20% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep.	CLICK TO VIEW
CR5038	Colorectal Cancer	ADC	metastatic colon carcinoma adenocarcinoma. Pathol comment: c/w diagnosis. approximately 60% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep.	CLICK TO VIEW
CR5039	Colorectal Cancer	NA	colon carcinoma. Pathol comment: c/w diagnosis. approximately 50% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep.	CLICK TO VIEW
CR5040	Colorectal Cancer	ADC	colon carcinoma adenocarcinoma. Pathol comment: c/w diagnosis. approximately 60% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep.	CLICK TO VIEW
CR5043	Colorectal Cancer	ADC	metastatic colon carcinoma adenocarcinoma. Pathol comment: c/w diagnosis. approximately 20% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep.	CLICK TO VIEW
CR5044	Colorectal Cancer	NA	colon carcinoma. Pathol comment: c/w diagnosis. approximately 40% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep.	CLICK TO VIEW
CR5046	Colorectal Cancer	ADC	colon carcinomametastatic rectal adenocarcinoma. Pathol comment: c/w diagnosis. approximately 75% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep.	CLICK TO VIEW
CR5048	Colorectal Cancer	ADC	colon cancer metastatic adenocarcinoma. Pathol comment: c/w diagnosis. approximately 40% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep.	CLICK TO VIEW
CR5052	Colorectal Cancer	ADC	colon carcinoma metastatic adenocarcinoma c/w colon primary. Pathol comment: c/w diagnosis. approximately 80% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep.	CLICK TO VIEW
CR5053	Colorectal Cancer	NA	colon carcinoma. Pathol comment: c/w diagnosis. approximately 70% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep.	CLICK TO VIEW
CR5055	Colorectal Cancer	NA	colon carcinoma metastatic colon cancer. Pathol comment: c/w diagnosis. approximately 70% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep.	CLICK TO VIEW
CR5058	Colorectal Cancer	ADC	colon carcino mametastatic colonic adenocarcinoma. Pathol comment: c/w referring diagnosis. microscopic focus of malignant tumor present in sections examined. malignant tumor cells present in cytospin prep.	CLICK TO VIEW
CR5059	Colorectal Cancer	ADC	colon carcinoma metastatic adenocarcinoma, pd. Pathol comment: c/w diagnosis. approximately 60% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep.	CLICK TO VIEW
CR5062	Colorectal Cancer	NA	R Colon Carcinoma. Pathol comment: c/w diagnosis. Approx. 40% of the tissue involved by malignant tumor in sectionss examined. 20% necrotic malignant tumor cells in cytospin prep.	CLICK TO VIEW
CR5063	Colorectal Cancer	Signet ring cell carcinoma	colon carcinoma signet ring cell carcinoma. Pathol comment: c/w referring diagnosis. malignant tumor cells present in cell block and cytospin prep.	CLICK TO VIEW
CR5066	Colorectal Cancer	NA	colon carcinoma. Pathol comment: c/w diagnosis. approximately 20% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep.	CLICK TO VIEW
CR5067	Colorectal Cancer	ADC	colon cancer metastatic adenocarcinoma. Pathol comment: c/w diagnosis. approximately 50% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep.	CLICK TO VIEW
CR5072	Colorectal Cancer	Mucinous adenocarcinoma	colon carcinoma mucinous adenocarcinoma, g2, md. Pathol comment: c/w diagnosis. approximately 10% of the detached tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep.	CLICK TO VIEW
CR5073	Colorectal Cancer	NA	colon carcinoma. Pathol comment: c/w diagnosis. approximately 90% of the tissue involved by malignant tumor in sections examined. 10% necrotic. malignant tumor cells present in cytospin prep.	CLICK TO VIEW
CR5074	Colorectal Cancer	NA	colon carcinoma. Pathol comment: c/w diagnosis. approximately 40% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep.	CLICK TO VIEW
CR5075	Colorectal Cancer	NA	colon carcinoma. Pathol comment: c/w diagnosis. approximately 100% of the tissue involved by malignant tumor in sections examined. 30% necrotic. malignant tumor cells present in cytospin prep.	CLICK TO VIEW
CR5079	Colorectal Cancer	ADC	N/A	CLICK TO VIEW
CR5080	Colorectal Cancer	ADC	colon carcinoma metastatic colon adenocarcinoma. Pathol comment: c/w diagnosis. approximately 80% of the tissue involved by malignant tumor in sections examined. 95% necrosis. approximately 30% malignant tumor cells present in cytospin preparation.	CLICK TO VIEW
CR5081	Colorectal Cancer	NA	rectal carcinoma metastatic carcinoma. Pathol comment: c/w diagnosis. microscopic focus of malignant tumor present in tissue sections examined. focal tumor necrosis. c/w adenocarcinoma. approximately 20% malignant tumor cells present in cytospin preparation.	CLICK TO VIEW
CR5082	Colorectal Cancer	NA	rectal cancer metastatic anaplastic malignant epithelial cells. Pathol comment: malignant tumor cells present in cell block. approximately 70% malignant tumor cells present in cytospin preparation. c/w diagnosis.	CLICK TO VIEW
CR5083	Colorectal Cancer	ADC	colon carcinoma adenocarcinoma, grade ii, c/w metastatic colon carcinoma. Pathol comment: c/w diagnosis. approximately 90% of the tissue involved by malignant tumor in sections examined. 40% necrosis. approximately 50% malignant tumor cells present in cytospin preparation. extracellular mucin and necrosis are present.	CLICK TO VIEW
CR5084	Colorectal Cancer	NA	colon carcinoma and adenocarcinoma showing neuroendocrine features. Pathol comment: c/w diagnosis. approximately 10% of the tissue involved by malignant tumor in sections examined. focal tumor necrosis. approximately 60% malignant tumor cells present in cytospin preparation. abundant extracellular mucin present.	CLICK TO VIEW
CR5085	Colorectal Cancer	NA	colon carcinoma. Pathol comment: c/w diagnosis. approximately 30% of the tissue involved by malignant tumor in sections examined. approximately 10% malignant tumor cells present in cytospin preparation.	CLICK TO VIEW
CR5087	Colorectal Cancer	NA	colon carcinoma carcinoma. Pathol comment: c/w diagnosis. approximately 10% of the tissue involved by malignant tumor in sections examined. focal tumor necrosis. approximately 20% malignant tumor cells present in cytospin preparation.	CLICK TO VIEW
CR5088	Colorectal Cancer	NA	Colon carcinoma. Pathol comment: c/w with diagnosis. Approximately 70% of the tissue involved by malignant tumor in sections examined. Focal tumor necrosis. Approximately 70% malignant tumor cells present in cytospin preparation.	CLICK TO VIEW
CR5090	Colorectal Cancer	NA	colon carcinoma. Pathol comment: no viable tumor present in tissue sections examined. extensive necrosis. approximately 60% malignant tumor cells present in cytospin preparation. c/w diagnosis.	CLICK TO VIEW
CR5091	Colorectal Cancer	NA	colon carcinoma poorly differentiated carcinoma. Pathol comment: c/w diagnosis. approximately 70% of the tissue involved by malignant tumor in sections examined. 30% necrosis. approximately 50% malignant tumor cells present in cytospin preparation.	CLICK TO VIEW
CR5092	Colorectal Cancer	NA	colon carcinoma. Pathol comment: malignant tumor cells present in cell block. approximately 10% malignant tumor cells present in cytospin preparation. c/w diagnosis.	CLICK TO VIEW
CR5093	Colorectal Cancer	NA	colon carcinoma carcinoma. Pathol comment: approximately 60% of the tissue involved by malignant tumor in sections examined. 5% necrosis. c/w adenocarcinoma. approximately 80% malignant tumor cells present in cytospin preparation.	CLICK TO VIEW
CR5095	Colorectal Cancer	Colon (BRAF mut)	Colon carcinoma. Pathol comment:c/w diagnosis. approximately 10% of the tissue involved by malignant tumor in sections examined. approximately 40% malignant tumor cells present in cytospin preparation. abundant extracellular mucin. Abundant extracellular mucin.	CLICK TO VIEW
CR5098	Colorectal Cancer	ADC	colon carcinoma moderately differentiated adenocarcinoma c/w colonic primary.	CLICK TO VIEW
CR5100	Colorectal Cancer	NA	colon carcinoma.	CLICK TO VIEW
CR5101	Colorectal Cancer	ADC	colon carcinoma metastatic colonic adenocarcinoma.	CLICK TO VIEW
CR5103	Colorectal Cancer	ADC	colonic adenocarcinoma grade 2. figo iv.	CLICK TO VIEW
CR6217	Colorectal Cancer	ADC	Adenocarcinoma of sigmoid, infiltrating through intestinal wall to adipose tissue. Two of twelve lymph nodes involoved by metastatic carcinoma (2/12)	CLICK TO VIEW
CR6218	Colorectal Cancer	ADC	Tubular adenocarcinoma of sigmoid colon, grade II, infiltrating through intestinal wall to adipose tissue. One of twelve lymph nodes involoved by metastatic carcinoma (1/12)	CLICK TO VIEW
CR6219	Colorectal Cancer	ADC	Tubular adenocarcinoma of sigmoid colon, grade II	CLICK TO VIEW
CR6221	Colorectal Cancer	ADC	Tubular adenocarcinoma of juncture of sigmoid colon and rectum, grade II, infiltrating to superficial muscularis. All lymph nodes are benign (0/12).	CLICK TO VIEW
CR6222	Colorectal Cancer	ADC	Adenocarcinoma of rectum, grade II, infiltrating to pericolonal adipose tissue. One of fifteen lymph nodes involved by metastatic carcinoma (1/15).	CLICK TO VIEW
CR6223	Colorectal Cancer	ADC	Moderately differentiated adenocarcinoma of rectum, infiltrating to intestinal surrounding fibrofatty tissue. All lymph nodes are benign (0/12).	CLICK TO VIEW
CR6224	Colorectal Cancer	ADC	Adenocarcinoma of sigmoid colon, grade II, infiltrating to intestinal surrounding fibrofatty tissue. Five of fourteen lymph nodes involved by metastatic carcinoma (5/14).	CLICK TO VIEW
CR6225	Colorectal Cancer	ADC	Tubular adenocarcinoma of colon, with mucinous adenocarcinoma component. Tumor invaded to subserosal fat tissue, no lymph nodes involved by metastatic carcinoma (0/12).	CLICK TO VIEW
CR6226	Colorectal Cancer	ADC	Moderately differentiated adenocarcinoma, with mucinous adenocarcinoma component. Tumor invaded to serosa, four of twenty-five lymph nodes involved by metastatic carcinoma (4/25).	CLICK TO VIEW
CR6227	Colorectal Cancer	ADC	Moderately to poorly differentiated adenocarcinoma of rectum, infiltrating to intestinal adventitia. Three of twenty-one lymph nodes involved by metastatic carcinoma (3/21).	CLICK TO VIEW
CR6229	Colorectal Cancer	ADC	Moderately differentiated adenocarcinoma of head of pancreas, infiltrating to common bile duct. One of nine lymph nodes involved by metastatic carcinoma (1/9).	CLICK TO VIEW
CR6234	Colorectal Cancer	ADC, tubular	Colon: moderately differentiated tubular adenocarcinoma, the tumor infiltrated to subserosal fat tissue.	CLICK TO VIEW
CR6235	Colorectal Cancer	ADC	Transverse colon: adenocarcinoma, grade II, infiltrating to serosa. Six of twenty-five lymph nodes involved by metastatic carcinoma (6/25).	CLICK TO VIEW
CR6241	Colorectal Cancer	ADC	Tubular adenocarcinoma of transverse colon, moderately differentiated, infiltrating to serosa.	CLICK TO VIEW
CR6242	Colorectal Cancer	ADC	Tubular adenocarcinoma of rectum, grade II, infiltrating to superficial muscularis. All lymph nodes are benign (0/14).	CLICK TO VIEW
CR6243	Colorectal Cancer	ADC	Papillary, tubular adenocarcinoma of ileocecal junction, grade II, infiltrating to serosa. One of twelve lymph nodes involved by metastatic carcinoma (1/12).	CLICK TO VIEW
CR6244	Colorectal Cancer	ADC	Adenocarcinoma of rectum, grade II. Tumor invaded surrounding fatty tissue. All lymph nodes are benign (0/11).	CLICK TO VIEW
CR6248	Colorectal Cancer	ADC	Tubular adenocarcinoma of sigmoid, grade II, infiltrating to subserosal fat tissue.	CLICK TO VIEW
CR6249	Colorectal Cancer	ADC	Ileocecal junction: moderately-poorly differentiated adenocarcinoma, with musinous adenocarcinoma component. Tumor invade through intestinal wall to fibrofatty tissue. One of seven lymph nodes involved by metastatic carcinoma.	CLICK TO VIEW
CR6250	Colorectal Cancer	ADC	Tubular adenocarcinoma of colon, grade II, stage pT3N0Mx. All lymph nodes are benign (0/11).	CLICK TO VIEW
CR6251	Colorectal Cancer	ADC	Adenocarcinoma of rectum, grade II. Tumor invaded deep muscularis	CLICK TO VIEW
CR6252	Colorectal Cancer	ADC	Transverse colon: papillary, tubular adenocarcinoma, grade II. Tumor invaded through intestinal wall to fibrofatty tissue, all lymph nodes are benign (0/10).	CLICK TO VIEW
CR6253	Colorectal Cancer	ADC	Adenocarcinoma of colon, grade II-III, stage T3N0M0. Tumor invaded to serosa, all lymph nodes are benign (0/18).	CLICK TO VIEW
CR6254	Colorectal Cancer	ADC	Adenocarcinoma of rectum, moderately differentiated.	CLICK TO VIEW
CR6255	Colorectal Cancer	ADC	Descending colon: adenocarcinoma, grade II, infiltrating to subserosa. All lymph nodes are benign (0/13).	CLICK TO VIEW
CR6256	Colorectal Cancer	ADC	Tubular adenocarcinoma of rectum, grade II. Tumor invaded through intestinal wall to fibrofatty tissue, with metastasis in lymph nodes (3/11) and two carcinomatous nodule formation.	CLICK TO VIEW
CR6257	Colorectal Cancer	ADC, tubular	Ascending colon: moderately differentiated tubular adenocarcinoma, the tumor infiltrated to serosa. All lymph nodes are benign (0/26).	CLICK TO VIEW
CR6267	Colorectal Cancer	ADC	Moderately differentiated adenocarcinoma of rectum	CLICK TO VIEW
CR6269	Colorectal Cancer	SCC, Anal canal	Anal canal: squamous cell carcinoma, grade II. Metastatic carcinoma involves 7 of 14 lymph nodes and 4 carcniomatous nodule formation.	CLICK TO VIEW
CR6286	Colorectal Cancer	ADC, tubular	Sigmoid colon: moderately differentiated tubular adenocarcinoma, the tumor infiltrated to serosa. Four out of fourteen lymph nodes showed metastatic adenocarcinoma.	CLICK TO VIEW
CR6287	Colorectal Cancer	Mucinous adenocarcinoma	N/A	CLICK TO VIEW
CR6289	Colorectal Cancer	ADC	Tubular adenocarcinoma, grade II	CLICK TO VIEW
CR6290	Colorectal Cancer	ADC	Poorly differentated tubular adenocarcinoma	CLICK TO VIEW
CR6309	Colorectal Cancer	NA	Metastatic colorectal carcinoma to liver	CLICK TO VIEW
CR6310	Colorectal Cancer	NA	Metastatic colorectal carcinoma to liver	CLICK TO VIEW
CR6447	Colorectal Cancer	ADC	Moderate differentiation.	CLICK TO VIEW
CR6453	Colorectal Cancer	ADC	Colorectal mets in segment VIII - complete resection with vascular and bile duct invasion	CLICK TO VIEW
CR6454	Colorectal Cancer	ADC	Liver histology: Metastatic colonic adenocarcinoma, liver mets.	CLICK TO VIEW
CR6455	Colorectal Cancer	ADC	Liver & regional lymph nodes - metastatic colorectal adenocarcinoma. Differentiation: moderate. Post Op survival: 13 months.	CLICK TO VIEW
CR6456	Colorectal Cancer	ADC	Liver histology: Moderately differentiated metastatic adenocarcinoma, liver mets. Past medical history: Lymphoma.	CLICK TO VIEW
CR6457	Colorectal Cancer	ADC	multiple liver mets; tumor size: 7 x 1 & 6 x 2. Post Op survival: 1 year.	CLICK TO VIEW
CR6458	Colorectal Cancer	NA	NA	CLICK TO VIEW
CR6460	Colorectal Cancer	ADC	Liver histology: Hepatic resection for mucinous adenocarcinoma posible intrahepatic spread	CLICK TO VIEW
CR6461	Colorectal Cancer	ADC	metastatic moderately differentiated adenocarcinoma with intrahepatic spread - excision is complete	CLICK TO VIEW
CR6620	Colorectal Cancer	NA	Sigmoid: adenocarcinoma, ulcerative type, grade II, infiltrating through intestinal wall to adipose tissue.	CLICK TO VIEW
CR6629	Colorectal Cancer	Adenocarcinoma	NA	CLICK TO VIEW
CR6689	Colorectal Cancer	ADC	Left lobe of liver: adenocarcinoma, grade II. Consider metastatic colon adenocarcinoma in liver on the basis of medical history and IHC results.	CLICK TO VIEW
CR6721	Colorectal Cancer	ADC	Left lobe of liver: adenocarcinoma, grade II-III. Metastatic colonic adenocarcinoma in liver, based on medical history, morphology and IHC results.	CLICK TO VIEW
CR6801	Colorectal Cancer	NA	NA for clinical diagnosis info.	CLICK TO VIEW
CR6804	Colorectal Cancer	NA	NA for clinical diagnosis info.	CLICK TO VIEW
CR6805	Colorectal Cancer	NA	NA for clinical diagnosis info.	CLICK TO VIEW
CR6847	Colorectal Cancer	NA	Sigmoid: poorly differentiated adenocarcinoma, infiltrating to subserosa adipose tissue.	CLICK TO VIEW
CR6848	Colorectal Cancer	ADC	Colon: moderately differentiated adenocarcinoma	CLICK TO VIEW
CR6849	Colorectal Cancer	ADC	Sigmoid colon: moderately differentiated adenocarcinoma. All lymph nodes are benign (0/11).	CLICK TO VIEW
CR6852	Colorectal Cancer	NA	NA for clinical diagnosis info.	CLICK TO VIEW
CR6853	Colorectal Cancer	NA	NA for clinical diagnosis info.	CLICK TO VIEW
CR6854	Colorectal Cancer	NA	Colon: well differentiated adenocarcinoma, infiltrating through serosa to adipose tissue.	CLICK TO VIEW
CR6856	Colorectal Cancer	NA	NA for clinical diagnosis info.	CLICK TO VIEW
CR6857	Colorectal Cancer	NA	Sigmoid: moderately differentiated adenocarcinoma, infiltrating through intestinal wall to adipose tissue. Eight of twenty-five lymph nodes involved by malignant carcinoma (8/25).	CLICK TO VIEW
CR6858	Colorectal Cancer	NA	Colon: moderately differentiated adenocarcinoma, infiltrating through intestinal wall to adipose tissue.	CLICK TO VIEW
CR6860	Colorectal Cancer	NA	Colon: moderately to poorly differentiated adenocarcinoma, infiltrating to adipose tissue.	CLICK TO VIEW
CR6861	Colorectal Cancer	NA	Sigmoid: mucinous adenocarcinoma (90%) with poorly differentiated adenocarcinoma (10%).	CLICK TO VIEW
CR6863	Colorectal Cancer	ADC	Colon: moderately to poorly differentiated adenocarcinoma (60%), with mucinous component (40%), infiltrating to subserosa. Ten of twenty-two lympho nodes involved by malignant carcinoma (10/22).	CLICK TO VIEW
CR6909	Colorectal Cancer	ADC	Metastatic poorly differentiated adenocarcinoma (derived from sigmoid colon)	CLICK TO VIEW
CR6924	Colorectal Cancer	NA	Rectum: moderately differentiated adenocarcinoma, infiltrating to muscular layer.	CLICK TO VIEW
CR6925	Colorectal Cancer	ADC	Rectum: moderately differentiated adenocarcinoma, infiltrating through intestinal wall. All lymph nodes are benign (0/16).	CLICK TO VIEW
CR6927	Colorectal Cancer	NEC	Rectum: small cell neuroendocrine carcinoma (G3), infiltrating through intestinal wall.	CLICK TO VIEW
CR9250	Colorectal Cancer	NA	NA	CLICK TO VIEW
CR9252	Colorectal Cancer	ADC	N/A	CLICK TO VIEW
CR9253	Colorectal Cancer	ADC, mucinous	NA	CLICK TO VIEW
CR9255	Colorectal Cancer	NA	NA	CLICK TO VIEW
CR9256	Colorectal Cancer	Adenocarcinoma	NA	CLICK TO VIEW
CR9260	Colorectal Cancer	NA	NA	CLICK TO VIEW
CR9263	Colorectal Cancer	Adenocarcinoma	NA	CLICK TO VIEW
CR9264	Colorectal Cancer	Adenocarcinoma	NA	CLICK TO VIEW
CR9268	Colorectal Cancer	ADC	N/A	CLICK TO VIEW

…

Create Account to View All Model Data

First Name*

Last Name*

Company*

E-mail address*

Job Role

Country/Region*

Create Your Password*

Already Registered? Login

Patient-Derived Xenograft Models of Colorectal Cancer

Benefits of Crown Bioscience's Colon cancer Patient derived xenograft model research

Sorry, no posts matched your criteria.

Create Account to View All Model Data

About Us

Our Services

Resources

Platforms

Talk To Us